NuVasive (NUVA +13%) moves up after beating on its Q3 bottom and top line numbers today. The...
NuVasive (NUVA +13%) moves up after beating on its Q3 bottom and top line numbers today. The company lowers guidance going forward, now expecting FY12 revenue of between $601M to $606M on earnings of $0.88 to $0.90 per share. However, the company also noted that it's aggressively moving to replenish its diminished salesforce that led to flat third-quarter sales growth in its spinal division.
From other sites
Video at CNBC.com (Jul 13, 2016)
Video at CNBC.com (Jun 3, 2016)
at CNBC.com (Oct 4, 2012)
at CNBC.com (Oct 3, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs